Contribution of Co-detected Respiratory Viruses and Patient Age to the Clinical Manifestations of Mycoplasma Pneumoniae Pneumonia in Children

Background: The clinical spectrum of Mycoplasma pneumoniae pneumonia is widely variable. This study evaluated the clinical manifestations of M. pneumoniae pneumonia in children of different age groups and by the presence of co-detected respiratory virus. Methods: This study included children hospitalized with M. pneumoniae pneumonia between 2010 and 2015. At the time of pneumonia diagnosis, a nasopharyngeal aspirate was analyzed for respiratory viruses by reverse transcription-polymerase chain reaction (RT-PCR). The clinical manifestations and laboratory findings were reviewed from medical records. Results: Of the 286 children with M. pneumoniae pneumonia, 84 (29.4%) had a co-detected respiratory virus, with the highest co-detection rate in young children (51.9% of children <2 years; P = 0.002). In children <2 years, with and without co-detected virus, wheezing occurred in 35.7% and 15.4%, respectively. Among the 202 children without any virus detected, only 6.4% were <2 years. These young children showed fewer median days of fever than the children ≥2 years (8 vs. 11 days; P = 0.022). Children ≥2 years tended to have accompanying skin rashes (21.7% vs.7.7%; P = 0.310) and elevated liver enzymes (21.7% vs. 0%; P = 0.075) more frequently than children <2 years. Only 53.8% of the patients <2 years were treated with macrolide compared with 94.1% of the patients ≥2 years (P < 0.001). Conclusions: The clinical manifestations of M. pneumoniae pneumonia in young children are milder than those in older children. A high prevalence of co-detected respiratory virus in young children suggests that virus might play a role in making pneumonia clinically apparent in this age group.

[1]  D. Nadal,et al.  Infection with and Carriage of Mycoplasma pneumoniae in Children , 2016, Front. Microbiol..

[2]  Maureen H Diaz,et al.  Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia , 2016, Open forum infectious diseases.

[3]  M. Narita Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis , 2016, Front. Microbiol..

[4]  Linding Wang,et al.  Decreased Interleukin-10 Responses in Children with Severe Mycoplasma pneumoniae Pneumonia , 2016, PloS one.

[5]  Yhu-Chering Huang,et al.  Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: A nationwide surveillance. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[6]  Zhengrong Chen,et al.  Epidemiology and clinical profiles of Mycoplasma pneumoniae infection in hospitalized infants younger than one year. , 2015, Respiratory medicine.

[7]  P. Sly,et al.  Viral bacterial co-infection of the respiratory tract during early childhood. , 2015, FEMS microbiology letters.

[8]  C. Chiu,et al.  Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[9]  Anami R Patel,et al.  Community-acquired pneumonia requiring hospitalization among U.S. children. , 2015, The New England journal of medicine.

[10]  C. Vink,et al.  Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance , 2014, Current opinion in infectious diseases.

[11]  E. Postlethwait,et al.  Innate immune response to LPS in airway epithelium is dependent on chronological age and antecedent exposures. , 2013, American journal of respiratory cell and molecular biology.

[12]  Jae Hong Choi,et al.  Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011 , 2013, Emerging infectious diseases.

[13]  W. Hop,et al.  Carriage of Mycoplasma pneumoniae in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study , 2013, PLoS medicine.

[14]  D. Eibach,et al.  Increased detection of Mycoplasma pneumoniae infection in children, Lyon, France, 2010 to 2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  D. Fleming,et al.  Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  J. Siegel,et al.  Fatal outcomes in family transmission of Mycoplasma pneumoniae. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  O. Ruuskanen,et al.  Viruses and bacteria in sputum samples of children with community‐acquired pneumonia , 2011, Clinical Microbiology and Infection.

[18]  E. Avner,et al.  Introduction to the Child with Proteinuria , 2011 .

[19]  Jung-Woo Rhim,et al.  Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia , 2010, BMC pediatrics.

[20]  R. Willers,et al.  Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection , 2010, Journal of Clinical Virology.

[21]  G. Rossi,et al.  Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. , 2008, Respiratory medicine.

[22]  N. Kim,et al.  Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. , 2008, The Journal of infection.

[23]  N. Kim,et al.  Comparison of Polymerase Chain Reaction and the Indirect Particle Agglutination Antibody Test for the Diagnosis of Mycoplasma pneumoniae Pneumonia in Children During Two Outbreaks , 2007, The Pediatric infectious disease journal.

[24]  D. Isaacs,et al.  Mycoplasma pneumoniae infections in Australian children , 2005, Journal of paediatrics and child health.

[25]  Kurt Olsen,et al.  Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. , 2004, Pediatrics.

[26]  K. Waites New concepts of Mycoplasma pneumoniae infections in children , 2003, Pediatric pulmonology.

[27]  Hidehiro Watanabe,et al.  Animal Model of Mycoplasma pneumoniae Infection Using Germfree Mice , 2002, Clinical and Vaccine Immunology.

[28]  S. Esposito,et al.  Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. , 2001, The Lancet. Infectious diseases.

[29]  Hiroshi Tanaka,et al.  Significant Role of Interleukin-8 in Pathogenesis of Pulmonary Disease Due to Mycoplasma pneumoniaeInfection , 2001, Clinical Diagnostic Laboratory Immunology.

[30]  F. Blasi,et al.  Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Outbreak of community-acquired pneumonia caused by Mycoplasma pneumoniae--Colorado, 2000. , 2001, MMWR. Morbidity and mortality weekly report.

[32]  Hiroshi Tanaka,et al.  Close Association between Pulmonary Disease Manifestation in Mycoplasma pneumoniae Infection and Enhanced Local Production of Interleukin-18 in the Lung, Independent of Gamma Interferon , 2000, Clinical Diagnostic Laboratory Immunology.

[33]  J. Grigg,et al.  Alveolar macrophage immaturity in infants and young children. , 1999, The European respiratory journal.

[34]  O. Ruuskanen,et al.  Diagnosis of Mycoplasma pneumoniaePneumonia in Children , 1998, Journal of Clinical Microbiology.

[35]  D. Taylor-Robinson,et al.  Mycoplasma and ureaplasma infections. , 1998, Methods in molecular medicine.

[36]  O. Ruuskanen,et al.  Diagnosis of Mycoplasma pneumoniaePneumonia in Children , 1998, Journal of Clinical Microbiology.

[37]  Jin Young Park,et al.  Occurrence of Mycoplasma pneumoniae Pneumonia in Seoul, Korea, from 1986 to 1995 , 1997 .

[38]  H. Tanaka,et al.  Effects of interleukin-2 and cyclosporin A on pathologic features in Mycoplasma pneumonia. , 1996, American journal of respiratory and critical care medicine.

[39]  K. Yamamoto,et al.  Isolation of Mycoplasma pneumoniae from children with lower-respiratory-tract infections. , 1988, The Journal of infectious diseases.